Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Breast Cancer Reports
Erschienen in: Current Breast Cancer Reports 4/2020

25.08.2020 | Lymphedema Incidence, Prevention and Treatment (J Armer, Section Editor)

Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review

verfasst von: L. H. Eaton, N. Narkthong, J. M. Hulett

Erschienen in: Current Breast Cancer Reports | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Breast cancer-related lymphedema (BCRL) is a chronic disease affecting breast cancer survivors. The purpose of this article is to update the scientific literature regarding psychosocial issues associated with BCRL.

Recent Findings

Reports describe economic burdens, social support, sexuality, BCRL patient-education needs, and interventions to reduce BCRL symptoms and improve QOL among women with breast cancer. The psychosocial impact of BCRL may differ between younger and older women which has implications for age-related interventions to reduce the adverse psychosocial experiences of women with BCRL. We did not locate studies reporting the psychosocial impact of BCRL on male breast cancer survivors.

Summary

More psychosocial-based interventions are needed that target the concerns of those with BCRL, including age-related needs, sexual concerns, body image, and social support. Future research is indicated to study the psychosocial impact of BCRL among men. Researchers may consider how pandemic-driven health care policies affect the psychosocial needs of those with BCRL.
Literatur
1.
American Cancer Society. Cancer facts & figures. Atlanta: American Cancer Society; 2020.
2.
3.
Casley-Smith JR. Volume alterations in lymphoedema; untreated, and after complex therapy (CPT), benzopyrones, or both. Lymphology. 1994;27:627–31.
4.
•• Belmonte R, Messaggi-Sartor M, Ferrer M, Pont A, Escalada F. Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB. Supportive Care Canc. 2018;26(9):3277–87 This study followed 68 SLNB and 44 ALND patients presurgery to 5 years post-surgery and found the ALND group had significant loss of internal rotator strength (p = .0001) and increased limb volume (p = .03) compared with the SLNB group (p < .001). Furthermore, the ALND had more BCRL (33.3%) than those receiving SLNB (3.4%) (p < .001).
5.
Armer JM, Stewart BR. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology. 2010;43(3):118–27.PubMedPubMedCentral
6.
Bell RJ, Penelope J, Robinson RB, Fradkin P, Schwarz M, Davis SR. Lymphedema: experience of a cohort of women with breast cancer followed for 4 years after diagnosis in Victoria. Australia Supportive Care Canc. 2013;21(7):2017–24.
7.
Taghian NR, Miller CL, Jammallo LS, O’Toole J, Skolny MN. Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol. 2014;92(3):227–34.PubMed
8.
Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psycho-Oncology. 2013;22(7):1466–84.PubMed
9.
• Kibar S, Dalyan Aras M, Ünsal DS. The risk factors and prevalence of upper extremity impairments and an analysis of effects of lymphoedema and other impairments on the quality of life of breast cancer patients. Eur J Canc Care. 2017;26(4):1–10 This study of 201 breast cancer survivors demonstrated an incidence rate of 41.3% and lymphedema was the primary risk factor for developing upper extremity impairment and subsequently diminishing QOL.
10.
Velloso FSB, Barra AA, Dias RC. Functional performance of upper limb and quality of life after sentinel lymph node biopsy of breast cancer. Rev Bras Fis. 2011;15(2):146–53.
11.
Chachaj A, Małyszczak K, Pyszel K, Lukas J, Tarkowski R, Pudełko M, et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. PsychoOnc. 2010;19(3):299–305.
12.
Nesvold IL, Fossa SD, Holm I, Naume B, Dahl AA. Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncol. 2010;49(3):347–53.PubMed
13.
Teo I, Fingeret MC, Liu J, Chang DW. Coping and quality of life of patients following microsurgical treatment for breast cancer-related lymphedema. J Health Psychol. 2016;21(12):2983–93.PubMed
14.
Penha T, Botter B, Heuts E, Voogd A, von Meyenfeldt M, van der Hulst R. Quality of life in patients with breast cancer–related lymphedema and reconstructive breast surgery. J Reconstr Microsurg. 2016;32(6):484–90.PubMed
15.
Jeong HJ, Sim YJ, Hwang KH, Kim GC. Causes of shoulder pain in women with breast cancer-related lymphedema: a pilot study. Yonsei Med J. 2011;52(4):661–7.PubMedPubMedCentral
16.
Khan F, Amatya B, Pallant JF, Rajapaksa I. Factors associated with long-term functional outcomes and psychological sequelae in women after breast cancer. Breast. 2012;21(3):314–20.PubMed
17.
Delgado-Sanz MC, García-Mendizábal MJ, Pollán M, Forjaz MJ, López-Abente G, Aragonés N, et al. Heath-related quality of life in Spanish breast cancer patients: a systematic review. Health Qual Life Outcomes. 2011;9(3):1–10.
18.
Vassard D, Halgren Olsen M, Zinckernagel L, Vibe-Petersen J, Oksbjerg Dalton S, Johansen C. Psychological consequences of lymphoedema associated with breast cancer: a prospective cohort xtudy. Eur Journal Canc Care. 2010;46(18):3211–8.
19.
Thomas A, Job K. Arm function and quality of life among patients after mastectomy. J Clin Diagn Res. 2018;12(4):XC01–XC4.
20.
• Bjerkeset E, Röhrl K, Schou-Bredal I. Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics. Breast Cancer Res Treat. 2020;180(1):63–71 This study of breast cancer survivors (n=834) reported 13% of participants had symptom clusters of pain, fatigue, and psychological distress. Factors associated with symptoms clusters included BCRL, younger age, working part-time, or being disabled (all p < .05).PubMedPubMedCentral
21.
Dominick SA, Natarajan L, Pierce JP, Madanat H, Madlensky L. The psychosocial impact of lymphedema-related distress among breast cancer survivors in the WHEL study. Psycho-Oncology. 2014;23(9):1049–56.PubMedPubMedCentral
22.
Taira N, Shimozuma K, Shiroiwa T, Ohsumi S, Kuroi K, Saji S, et al. Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery. Breast CancRes Treat. 2011;128(3):735–47.
23.
Alcorso J, Sherman KA, Koelmeyer L, Mackie H, Boyages J. Perceived barriers to adherence to breast cancer-related lymphoedema self-management. J Lymphoedema. 2016;11(1):20–6.
24.
Boing L, Pereira GS, Araujo C, Sperandio FF, Loch M, Bergmann A, et al. Factors associated with depression symptoms in women after breast cancer. Rev Saude Publica. 2019;53:30.PubMedPubMedCentral
25.
Anbari AB, Wanchai A, Armer JM. Breast cancer-related lymphedema and quality of life: a qualitative analysis over years of survivorship. Chron Illness. 2019;0(0):1–12.
26.
Teo I, Novy DM, Chang DW, Cox MG, Fingeret MC. Examining pain, body image, and depressive symptoms in patients with lymphedema secondary to breast cancer. Psycho-Oncology. 2015;24(11):1377–83.PubMed
27.
Yang EJ, Kim SW, Heo CY, Lim JY. Longitudinal changes in sexual problems related to cancer treatment in Korean breast cancer survivors: a prospective cohort study. Support Care Cancer. 2011;19(7):909–18.PubMed
28.
Radina ME, Fu MR, Horstman L, Kang Y. Breast cancer-related lymphedema and sexual experiences: a mixed-method comparison study. Psycho-Oncology. 2015;24(12):1655–62.PubMed
29.
Winch CJ, Sherman KA, Koelmeyer LA, Smith KM, Mackie H, Boyages J. Sexual concerns of women diagnosed with breast cancer-related lymphedema. Supportive Care Canc. 2015;23(12):3481–91.
30.
Tsuchiya M, Miyako T. Psychosocial impact of lymphoedema after breast surgery. Curr Breast Cancer Rep. 2016;8(1):47–51.
31.
Penha Lopez TR, van Bodegraven J, Winkens B, Heuts EM, Voogd AC, von Meyenfeldt MF. The auality of life in long-term breast cancer survivors with breast cancer related lymphedema. Acta Chir Belg. 2014;114:239–44.
32.
Armer JM, Shook RP, Schneider MK, Brooks CW, Peterson J, Stewart BR. Enhancing supportive-educative nursing systems to reduce risk of post-breast cancer lymphedema. SelfCareDepend Care Nurs. 2009;17:6–15.
33.
Radina ME, Armer JM, Stewart BR. Making self-care a priority for women at risk of breast cancer–related lymphedema. J Fam Nurs. 2014;20(2):226–49.PubMed
34.
Tsuchiya M, Horn S, Ingham R. Social disclosure about lymphoedema symptoms: a qualitative study among Japanese breast cancer survivors. Psychol Health Med. 2015;20(6):680–4.PubMed
35.
Bulley C, Gaal S, Coutts F, Blyth C, Jack W, Chetty U, et al. Comparison of breast cancer-related lymphedema (upper limb swelling) prevalence estimated using objective and subjective criteria and relationship with quality of life. Biomed Res Int. 2013;2013:807569.PubMedPubMedCentral
36.
Sackey H, Johansson H, Sandelin K, Liljegren G, MacLean G, Frisell J, et al. Self-perceived, but not objective lymphoedema is associated with decreased long-term health related quality of life after breast cancer surgery. Eur J Surg Oncol. 2015;41(4):577–84.
37.
Popovic-Petrovic S, Kovac A, Kovac N, Tovilovic S, Novakov I, Culibrk D. Secondary lymphedema of the arm, the perception of the disease, self efficacy and depression as determinants of quality of life in patients with breast cancer. Vojnosanit Pregl. 2018;75(10):961–7.
38.
Lee SH, Min YS, Park HY, Jung TD. Health-related quality of life in breast cancer patients with lymphedema who survived more than one year after surgery. J Breast Cancer. 2012;15(4):449–53.PubMedPubMedCentral
39.
Bojinovic-Rodic D, Popovic-Petrovic S, Tomic S, Markez S, Zivanic D. Upper extremity function and quality of life in patients with breast cancer related lymphedema. Vojnosanit Pregl. 2016;73(9):825–30.PubMed
40.
da Silva RCM, Rezende LF. Assessment of impact of late postoperative physical functional disabilities on quality of life in breast cancer survivors. Tumori. 2014;100:87–90.
41.
Fantoni SQ, Peugniez C, Duhamel A, Skrzypczak J, Frimat P, Leroyer A. Factors related to return to work by women with breast cancer in northern France. J Occup Rehabil. 2010;20(1):49–58.PubMed
42.
• Vignes S, Fau-Prudhomot P, Simon L, Sanchez-Brechot ML, Arrault M, Locher F. Impact of breast cancer-related lymphedema on working women. Support Care Cancer. 2020;28(1):79–85 This study of 134 women with BCRL demonstrates that upper limb lymphedema impacts the careers of over half of the women studied (52.2%) due to severely impaired arm movement (p < .01).PubMed
43.
Dean LT, Schmitz KH, Frick KD, Nicholas LH, Zhang Y, Subramanian SV, et al. Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA. J Cancer Surviv. 2018;12(3):306–15.
44.
Azarkish F, Mirzaii Najmabadi K, Latifnejad Roudsari R, Homaei SF. Factors related to return to work in women after breast cancer in Iran. Iran Red Crescent Med J. 2015;17(9):e19978.PubMedPubMedCentral
45.
Peugniez C, Leroyer A, Skrzypczak J, Duprey M, Bonneterre J. Return to work after treatment for breast cancer: single center experience in a cohort of 273 patients. Bull Cancer. 2011;98(7):E69–79.PubMed
46.
Schmitz KH, DiSipio T, Gordon LG, Hayes SC. Adverse breast cancer treatment effects: the economic case for making rehabilitative programs standard of care. Support Care Cancer. 2015;23(6):1807–17.PubMed
47.
Zomkowski K, Cruz de Souza B, Pinheiro da Silva F, Moreira GM, de Souza Cunha N, Sperandio FF. Physical symptoms and working performance in female breast cancer survivors: a systematic review. Disabil Rehabil. 2018;40(13):1485–93.PubMed
48.
• Sun Y, Shigaki CL, Armer JM. Return to work among breast cancer survivors: a literature review. Support Care Cancer. 2017;25(3):709–18 This literature review of 25 articles reports on breast cancer survivors ability to return to work, work ability, and work performance and highlights a need for feasible interventions for supporting survivors’s return to work.PubMed
49.
Armer JM, Hulett JM, Bernas M, Ostby P, Stewart BR, Cormier J. Best practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Canc Res. 2013;5:134–44.
50.
Adams N, Gisiger-Camata S, Hardy CM, Thomas TF, Jukkala A, Meneses K. Evaluating survivorship experiences and needs among rural African American breast cancer survivors. J Cancer Educ. 2017;32(2):264–71.PubMed
51.
White JA, Matthews E, Wallace L, Poormon L. Informational needs of breast cancer patients related to lymphedema. Rehabil Oncol. 2015;33(1):58–63.
52.
Ostby PL, Armer JM, Smith K, Stewart BR. Patient perceptions of barriers to self-management of breast cancer-related lymphedema. WestJ Nurs Res. 2018;40(12):1800–17.
53.
Smith SL, Murchison S, Singh-Carlson S, Alexander C, Wai ES. Survivorship care in breast cancer. Can Fam Physician. 2015;61:e277–83.PubMedCentral
54.
Panobianco MS, Campacci N, Fangel LMV, Prado MAS, Almeida AMD, Gozzo TDO. Quality of life of women with lymphedema after surgery for breast cancer. Revista Da Rede de Enfermagem Do Nordeste. 2014;15(2):206–13.
55.
Bland KL, Kosir MA. Improving the quality of life in breast cancer survivors at risk for lymphedema. Surgery. 2019;166(4):686–90.PubMed
56.
Lin CY, Liu HE, Cheng MH. Factors associated with professional healthcare advice seeking in breast cancer–related lymphedema. J SurgOncol. 2019;121:67–74.
57.
• Ridner SH, Dietrich MS, Davis AJ, Sinclair V. A randomized clinical trial comparing the impact of a web-based multimedia intervention versus an educational pamphlet on patient outcomes in breast cancer survivors with chronic secondary lymphedema. J Women's Health. 2019;0(0):1–11 This intervention study examines the effects of a web-based multimedia intervention for BCRL patients and demonstrated superiority to using pamphlets in terms of providing high-quality self-care information (p = .001).
58.
Chang CJ, Cormier JN. Lymphedema interventions: exercise, surgery, and compression devices. Semin Oncol Nurs. 2013;29(1):28–40.PubMed
59.
Atalay OT, Özkir A, Başakçi cAlik B, Baskan E, Taşkin H. Effects of phase I complex decongestive physiotherapy on physical functions and depression levels in breast cancer related lymph edema. J PhysTher Sci. 2015;27(3):865–70.
60.
Park JE, Jang HJ, Seo KS. Quality of life, upper extremity function and the effect of lymphedema treatment in breast cancer related lymphedema patients. Ann Rehabil Med. 2012;36:240–7.PubMedPubMedCentral
61.
Yesil H, Eyigor S, Caramat I, Isik R. Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. Turk J Phys Med Rehabil. 2017;63(4):329–34.PubMedPubMedCentral
62.
Tunay VB, Akbayrak T, Kaya S. The effect of multidimensional physiotherapy program on shoulder function, pain, and lymphedema after surgery in elderly breast cancer patients. Top GeriatrRehabil. 2012;28(4):281–6.
63.
Melam GR, Buragadda S, Alhusaini AA, Arora N. Effect of complete decongestive therapy and home program on health- related quality of life in post mastectomy lymphedema patients. BMC Womens Health. 2016;16:23.PubMedPubMedCentral
64.
Park MW, Shi-Uk L, Sohyun K, Kwan SS. Comparison between the effectiveness of complex decongestive therapy and stellate ganglion block in patients with breast cancer-related lymphedema: a randomized controlled study. Pain Physician. 2019;22:255–63.PubMed
65.
Kim DS, Sim YJ, Jeong HJ, Kim GC. Effect of active resistive exercise on breast cancer-related lymphedema: a randomized controlled trial. Arch Phys Med Rehabil. 2010;91(12):1844–8.PubMed
66.
Abbasi B, Mirzakhany N, Oshnari LA, Irani A, Hosseinzadeh S, Tabatabaei SM, et al. The effect of relaxation techniques on edema, anxiety and depression in post-mastectomy lymphedema patients undergoing comprehensive decongestive therapy: a clinical trial. PLoS One. 2018;13(1):e0190231.
67.
Bahtiyarca ZT, Can A, Ekşioğlu E, Çakcı A. The addition of self-lymphatic drainage to compression therapy instead of manual lymphatic drainage in the first phase of complex decongestive therapy for treatment of breast cancer-related lymphedema: a randomized controlled, prospective study. Turkish J Phys Med Rehab. 2019;65(4):309–17.
68.
• Tantawy SA, Abdelbasset WK, Nambi G, Kamel DM. Comparative study between the effects of kinesio taping and pressure garment on secondary upper extremity lymphedema and quality of life following mastectomy: a randomized controlled trial. Integr Canc Ther. 2019;18:1–10 This RCT (n = 66) demonstrated Kinesiotaping reduced limb circumference, improved QOL, and improved hand grip strength among women with BCRL (p < .05) compared with pressure garments.
69.
Ochalek K, Gradalski T, Szygula Z, Partsch H. Physical activity with and without arm sleeves: compliance and quality of life after breast cancer surgery—a randomized controlled trial. Lymphat Res Biol. 2018;16(3):294–9.PubMed
70.
• Ochalek K, Partsch H, Gradalski T, Szygula Z. Do compression sleeves reduce the incidence of arm lymphedema and improve quality of life? Two-year results from a prospective randomized trial in breast cancer survivors. LymphatRes Bio. 2019;17(1):70–7 This pilot RCT (n = 41) offers preliminary data in support that wearing light compression sleeves reduces the incidence of early post-operative lymphedema and improves QOL.
71.
Loudon A, Barnett T, Piller N, Immink MA, Visentin D, Williams AD. The effect of yoga on women with secondary arm lymphoedema from breast cancer treatment. BMC Compl Alternative Med. 2012;12(1):1–9.
72.
Loudon A, Barnett T, Williams A. Yoga, breast cancer-related lymphoedema and well-being: a descriptive report of women’s participation in a clinical trial. J Clin Nurs. 2017;26(23):4685–95.PubMed
73.
Pasyar N, Tashnizi NB, Mansouri P, Tahmasebi S. Effect of yoga exercise on the quality of life and upper extremity volume among women with breast cancer related lymphedema: a pilot study. Eur J Oncol Nurs. 2019;42:103–9.PubMed
74.
Douglass J, Immink M, Piller N, Ullah S. Yoga for women with breast cancer related lymphoedema: a preliminary 6-month study. J Lymphoedema. 2012;7(2):30–8.
75.
Yao C, Xu Y, Chen L, Jiang H, Ki CS, Byun JS, et al. Effects of warm acupuncture on breast cancer-related chronic lymphedema: a randomized controlled trial. Curr Oncol. 2016;23(1):e27–34.PubMedPubMedCentral
76.
• Storz MA, Gronwald B, Gottschling S, Schöpe J, Mavrova R, Baum S. Photobiomodulation therapy in breast cancer-related lymphedema: a randomized placebo-controlled trial. Photodermatol Photoimmunol Photomed. 2017;33(1):32–40 This study is relatively unique in examining effects of photobiomodulation therapy among 40 women with lymphedema. Although null findings were reported for limb volume in this pilot RCT, PBMT was associated with improved QOL and reduced pain.PubMed
77.
Ridner SH, Poage-Hooper E, Kanar C, Doersam JK, Bond SM, Dietrich MS. A pilot randomized trial evaluating low-level laser therapy as an alternative treatment to manual lymphatic drainage for breast cancer-related lymphedema. Oncol Nurs Forum. 2013;40(4):383–93.PubMed
78.
Sohl SJ, Dietrich MS, Wallston KA, Ridner SH. A randomized controlled trial of expressive writing in breast cancer survivors with lymphedema. Psychol Health. 2017;32(7):826–42.PubMedPubMedCentral
79.
Whatley J, Street R, Kay S, Harris PE. Use of reflexology in managing secondary lymphoedema for patients affected by treatments for breast cancer: a feasibility study. Compl Ther Clin Pract. 2016;23:1–8.
80.
Temur K, Kapucu S. The effectiveness of lymphedema self-management in the prevention of breast cancer-related lymphedema and quality of life: a randomized controlled trial. Eur J Oncol Nurs. 2019;40:22–35.PubMed
81.
Gautam AP, Maiya AG, Vidyasagar MS. Effect of home-based exercise program on lymphedema and quality of life in female postmastectomy patients: pre-post intervention study. J Rehabil Res Dev. 2011;48(10):1261–8.PubMed
82.
Tidhar D, Katz-Leurer M. Aqua lymphatic therapy in women who suffer from breast cancer treatment-related lymphedema: a randomized controlled study. Support Care Cancer. 2010;18(3):383–92.PubMed
83.
• Sener HO, Malkoc M, Ergin G, Karadibak D, Yavuzsen T. Effects of clinical pilates exercises on patients developing lymphedema after breast cancer treatment: a randomized clinical trial. J Breast Health. 2017;13(1):16–22 This small RCT of 60 women with BCRL demonstrated that Pilates is safe for those with BCRL, improves social appearance anxiey and QOL, and offers preliminary data that Pilates may more effective in BCRL symptoms than standard lymphedema exercises (p < .05).PubMedPubMedCentral
84.
Cho Y, Do J, Jung S, Kwon O, Jeon JY. Effects of a physical therapy program combined with manual lymphatic drainage on shoulder function, quality of life, lymphedema incidence, and pain in breast cancer patients with axillary web syndrome following axillary dissection. Support Care Cancer. 2016;24(5):2047–57.PubMed
85.
Ha K, Choi S. The effect of a PNF technique program after mastectomy on lymphedema patients’ depression and anxiety. J PhysTher Sci. 2014;26(7):1065–7.
86.
Hormes JM, Bryan C, Lytle LA, Gross CR, Ahmed RL, Troxel AB, et al. Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors. Lymphology. 2010;43:1–13.
87.
Speck RM, Gross CR, Hormes JM, Ahmed RL, Lytle LA, Hwang WT, et al. Changes in the body image and relationship scale following a one-year strength training trial for breast cancer survivors with or at risk for lymphedema. Breast Canc ResTreat. 2010;121(2):421–30.
88.
• Iacorossi L, Gambalunga F, Molinaro S, Domenico RD, Giannarelli D, Fabi A. The effectiveness of the sport ‘dragon boat racing’ in reducing the risk of lymphedema incidence: an observational study. Cancer Nurs. 2019;42(4):323–31 This novel complementary approach demonstrates the dragon boat racing is safe among women with BCRL (n = 100), and dragon boat racing is associated with a decreased incidence of lymphedema and improved QOL among women participating in dragon boat racing compared with women who did not participate in dragon boat racing (4% vs. 26%, respectively).PubMed
89.
Schaverien MV, Munro KJ, Baker PA, Munnoch DA. Liposuction for chronic lymphoedema of the upper limb: 5 years of experience. J Plast Reconstr Aesthet Surg. 2012;65(7):935–4.PubMed
90.
• Hoffner M, Bagheri S, Hansson E, Manjer J, Troëng T, Brorson H. SF-36 shows increased quality of life following complete reduction of postmastectomy lymphedema with liposuction. Lymphat Res Biol. 2017;15(1):87–98 This study of 60 women with BCRL demonstrates that liposuction and controlled compression therapy (CCT) reduce lymphedema and improve QOL (p < .05).PubMedPubMedCentral
91.
• Phillips GSA, Gore S, Ramsden A, Furniss D. Lymphaticovenular anastomosis improves quality of life and limb volume in patients with secondary lymphedema after breast cancer treatment. Breast J. 2019;25(5):859–64 This study offers preliminary data supporting the use of lymphaticovenular anastomosis (LVA) to reduce limb volume among 37 women with early stage lymphedema (p < .005) and was associated with improved QOL (p < .005).PubMed
92.
• Winters H, Tielemans HJP, Hameeteman M, Paulus VAA, Beurskens CH, Slater NJ, et al. The efficacy of lymphaticovenular anastomosis in breast cancer-related lymphedema. Breast Cancer Res Treat. 2017;165(2):321–7 This pilot study of 29 women with unilateral lymphedema demonstrated that LVA reduces limb volume (p = .00 at 6 months and p = .02 at 12 months) among women with BCRL and improves QOL.
93.
• Cornelissen AJM, Kool M, Penha TRL, Keuter XHA, Piatkowski AA, Heuts E, et al. Lymphatico-Venous anastomosis as treatment for breast cancer-related lymphedema: a prospective study on quality of life. Breast Cancer Res Treat. 2017;163(2) This pilot study of LVA in 20 women with early stage BCRL did not demonstrate a significant decrease in limb volume. However, 85% of participants were able to discontinue the use of compression stockings and were associated with improved QOL.
94.
• Gratzon A, Schultz J, Secrest K, Lee K, Feiner J, Klein RD. Clinical and psychosocial outcomes of vascularized lymph node transfer for the treatment of upper extremity lymphedema after breast cancer therapy. Ann Surg Oncol. 2017;24(6):1475–81 This study examined vascularized lymph node transfer (VLNT) to the axilla in 50 women with BCRL and demonstrated decreased arm volume by 58.7% at 12 months. Corresponding decreases in pain (p < .01) and heaviness (p < .01) were observed. QOL improved over time (p < .01). Minor wound complications occurred in 17 patients.PubMed
95.
North American Association of Central Cancer Registries (NAACCR). Annual report to the nation on the status of cancer. Springfield: NAACCR; 2018.
96.
Jang DH, Kim MW, Oh SJ, Kim JM. The influence of arm swelling duration on shoulder pathology in breast cancer patients with lymphedema. PLoS One. 2015;10(11):e0142950-e.
Metadaten
Titel
Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review
verfasst von
L. H. Eaton
N. Narkthong
J. M. Hulett
Publikationsdatum
25.08.2020
Verlag
Springer US
Erschienen in
Current Breast Cancer Reports / Ausgabe 4/2020
Print ISSN: 1943-4588
Elektronische ISSN: 1943-4596
DOI
https://doi.org/10.1007/s12609-020-00376-x

Weitere Artikel der Ausgabe 4/2020

Current Breast Cancer Reports 4/2020 Zur Ausgabe

Radiation Oncology (W Woodward, Section Editor)

New Frontiers in Hypofractionation for Regional Nodal Irradiation in Breast Cancer

Lymphedema Incidence, Prevention and Treatment (J Armer, Section Editor)

Pathophysiology of Breast Cancer-Related Lymphoedema

Radiation Oncology (W Woodward, Section Editor)

Hypofractionated Whole Breast Radiotherapy and Boost in Early-Stage Breast Cancer

Lymphedema Incidence, Prevention and Treatment (J Armer, Section Editor)

Drugs and Breast Cancer–Related Lymphoedema (BCRL): Incidence and Progression

Breast Cancer Disparities (LA Newman, Section Editor)

Community Outreach and Engagement Strategies to Address Breast Cancer Disparities

Lymphedema Incidence, Prevention and Treatment (J Armer, Section Editor)

Breast Cancer–Related Lymphedema: Personalized Plans of Care to Guide Survivorship

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise